Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
about
Inflammation in depression: is adiposity a cause?The association between chronic pain and obesitySystemic alterations in plasma proteins from women with chronic widespread pain compared to healthy controls: a proteomic study.Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass indexPotential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey.Relationship between fibromyalgia and obesity in pain, function, mood, and sleep.Cerebral responses to innocuous somatic pressure stimulation following aerobic exercise rehabilitation in chronic pain patients: a functional magnetic resonance imaging studyImpact of fibromyalgia on functioning in obese patients undergoing comprehensive rehabilitation.Benefits of resistance exercise in lean women with fibromyalgia: involvement of IGF-1 and leptinEffect of milnacipran on body weight in patients with fibromyalgiaPredictors of fibromyalgia: a population-based twin cohort studyClinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome.Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin?Chronic Fatigue Syndrome and Chronic Widespread Pain in Adolescence: Population Birth Cohort Study.Fibromyalgia and obesity: the hidden link.Sleep disorders and fibromyalgia.Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.Fibromyalgia: A Critical and Comprehensive Review.Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Lebanon.The association of total and central body fat with pain, fatigue and the impact of fibromyalgia in women; role of physical fitness.Ambroxol for the treatment of fibromyalgia: science or fiction?Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate.Clinical symptoms in fibromyalgia are associated to overweight and lipid profile.Depression in obese patients with primary fibromyalgia: the mediating role of poor sleep and eating disorder features.Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial.Relationship of weight status with mental and physical health in female fibromyalgia patients.Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight/obesity.Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients.Obesity and sleepiness in women with fibromyalgia.Are there differences in quality of life, symptomatology and functional capacity among different obesity classes in women with fibromyalgia? The al-Ándalus project.Dietary aspects in fibromyalgia patients: results of a survey on food awareness, allergies, and nutritional supplementation.Association of body mass index with symptom severity and quality of life in patients with fibromyalgia.High fat diet sensitizes fibromyalgia-like pain behaviors in mice via tumor necrosis factor alpha.Relationships between body mass index, fat mass, muscle mass, and musculoskeletal pain in community residents.Controlled, cross-sectional, multi-center study of physical capacity and associated factors in women with fibromyalgia.Executive function impairments in fibromyalgia syndrome: Relevance of clinical variables and body mass index.The relationship between body mass index and pain, disease activity, depression and anxiety in women with fibromyalgia.
P2860
Q24635451-5814F920-720E-4668-AC29-481CFF70952AQ26800261-7270457E-8868-4B5E-8DC1-4F45998F647AQ33553977-88EB4C4F-C2A4-4CD4-95FC-1443CD89A55FQ33595115-B4CFE37D-07C6-42CB-A35B-D7F5F061BCE1Q33882623-44B1F2C6-703A-412D-9BE0-4CFF1249B30BQ34129961-0B8B8054-CA7C-442B-89B6-CBCB7BE6E068Q34134834-E1643DC7-A667-417A-A379-4DFF1F222E9DQ35117805-48C8CA85-0B1E-4639-AAB7-9DA05AB697EAQ36306712-3024F8A6-385C-48B6-8A02-EBDA74716D43Q36344060-82F1029B-AA7D-42F5-9245-267D14393F8DQ36468997-8FBBE7D5-5EC3-40DF-88EC-1076BA7204B3Q36538889-09B366F6-0258-4BA4-8D30-34ACCD906DD0Q36903348-CFE9EA82-7D62-4D85-8E0B-582811807328Q37685133-E7DD820D-3576-4404-B035-F415AB8E1573Q37863057-A38B9304-20C4-435E-9632-BEC7045CF4E8Q37877193-430AA1F9-8555-4308-BAD6-AD4D5A015DC7Q38090730-B559F802-6377-4BC5-9A0D-82A33FCA06E8Q38601633-A52D6C89-1772-4CD9-8EA3-6E72785EE549Q40740111-379F6A3A-3DAD-4F77-B716-3D0A5A58D9E2Q41193910-26543611-626B-4C99-B551-DB3FB3EA334FQ41483222-614AFC8F-6392-4206-9CE6-D7B1AE21BB16Q43988174-BCA23F0E-BA4C-43D3-BEA6-2C2198EFFBF2Q44961170-1E123658-A23A-4311-A158-4F7198AB25CBQ46176574-8C6CF3C1-7B33-4FF0-ABC1-656F697399C0Q46657565-DC19211F-088B-4D02-8439-789BFB36AAEDQ47331953-A323878C-52E7-4014-9E49-B75C74B2A09EQ47573772-76CD0B9E-6843-441A-A89D-BD05B24F9A76Q47918459-4CA23B73-8143-4189-9ACA-F8ACA4D45CD5Q48092195-BF37F554-F281-4C81-A04D-63084EA9A792Q48119705-76D860A7-6099-407B-8AD8-346C2A04FD3BQ48288903-76F4BAB3-FA04-40D1-A2DD-BF625AC09627Q48576972-46479D72-AAC7-4803-A747-F34FC2446A29Q50000860-4AA86EA9-3862-4844-886F-374B46027D02Q51115906-C27A3C30-FF64-4439-B92E-5C71B4293870Q55112660-CCCAF321-7AFF-4619-BDEE-F88EC8A6A8BEQ55252507-DB11A4F3-E145-4155-B332-314364A9A2D2Q55284663-48F7ACB1-A063-4BAA-A6A4-4BEB7BB82729
P2860
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@en
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@nl
type
label
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@en
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@nl
prefLabel
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@en
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@nl
P2093
P2860
P921
P1476
Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions.
@en
P2093
Akiko Okifuji
Chrisana Olson
David H Bradshaw
P2860
P304
P356
10.1007/S10067-009-1094-2
P577
2009-01-27T00:00:00Z